Ark Investment Management's high-profile stock picker Cathie Wood has bought stakes in CRISPR Therap

Amova Asset Management Americas Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ: CRSP) by

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead approved as

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid a

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $47.78, marking a -1.63% move

CRISPR Therapeutics AG (CRSP) reached $48.57 at the closing of the latest trading day, reflecting a

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates CRISPR Therapeutics (NASDAQ:CRSP) w

Citizens analyst Silvan Turkcan reiterates CRISPR Therapeutics (NASDAQ:CRSP) with a Market Outper

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery for

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Cathie Wood’s ARK Innovation ETF is shedding assets this year as it continues to underperform the te

Bernstein analyst William Pickering maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Market Per

Citigroup analyst Yigal Nochomovitz maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and ra

US stock futures lower, FreightCar America (RAIL) plunges after weak earnings. Other stocks moving l

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 wil

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.

  During Thursday, 849 stocks hit new 52-week lows.

Stocks That Hit 52-Week Lows On Monday